SCHEMBL7816319

SCHEMBL7816319

Cc1oc2c(NC(=O)c3cccnc3Cl)cccc2c1C(C)(C)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.47
HPGD P15428 1/20 0.47
HTT P42858 1/20 0.47
RXFP1 Q9HBX9 2/20 0.46
NPC1 O15118 2/20 0.46
KDM4E B2RXH2 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
RAB9A P51151 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
ALDH1A1 P00352 3/20 0.44
GAA P10253 2/20 0.44
PABPC1 P11940 2/20 0.44
EIF4H Q15056 2/20 0.44
POLB P06746 1/20 0.44
KMT2A Q03164 3/20 0.43
MEN1 O00255 1/20 0.43
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7824213 0.80 RAB9A (0.41) SMN1; SMN2HTTNPC1L3MBTL1RAB9A
SCHEMBL8799382 0.79 TYK2 (0.37) SMN1; SMN2RAB9AALDH1A1KMT2APDE4B
SCHEMBL8341754 0.79 TP53 (0.48) SMN1; SMN2HTTRXFP1NPC1RAB9A
SCHEMBL7827083 0.78 TYK2 (0.47) SMN1; SMN2HPGDHTTKDM4EL3MBTL1
SCHEMBL7827508 0.77 GPR35 (0.50) SMN1; SMN2HPGDHTTRXFP1KDM4E
SCHEMBL7816537 0.76 GPR35 (0.41) SMN1; SMN2HPGDNPC1RAB9AALDH1A1
SCHEMBL8345039 0.75 PDE4D (0.41) SMN1; SMN2HTTNPC1KDM4ERAB9A
SCHEMBL7825378 0.74 GAA (0.42) ALDH1A1GAAPOLBKMT2AMEN1
SCHEMBL7831836 0.74 MAPT (0.53) SMN1; SMN2HPGDHTTRXFP1NPC1
SCHEMBL8345841 0.73 GPR35 (0.39) SMN1; SMN2HPGDKDM4EALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0757682-B1 BENZOFURAN DERIVATIVES USEFUL AS INHIBITORS OF BONE RESORPTION FUJISAWA PHARMACEUTICAL CO (JP) 2001-06-20 EP disclosed
US-5858995-A ADMINISTERING TO HUMANS AND ANIMALS IN THE TREATMENT OF DISEASES CAUSED BY ABNORMAL BONE METABOLISM FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-01-12 US disclosed
WO-1995029907-A1 BENZOFURAN DERIVATIVES USEFUL AS INHIBITORS OF BONE RESORPTION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1995-11-09 WO disclosed